Here are the 10-Q quarterly reports from Horizon Space Acquisition II Corp. Right (HSPTR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HSPTR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HSPTR filings page.
Horizon Space Acquisition II Corp. reported a small net loss of $29,122 for the quarter ended March 31, 2026, as interest income of $588,076 on its Trust investments was more than offset by formation and operating costs of $364,905 and interest expense of $252,293.
The SPAC redeemed 3,219,311 ordinary shares for $34,221,276, reducing the Trust Account to $39,390,860 and leaving a working capital deficit of $1,784,554. It continues to pursue the SL Bio business combination, supported by a $7,800,000 PIPE and multiple extension deposits, but management discloses substantial doubt about the company’s ability to continue as a going concern if a deal is not completed by the current deadline.